SUBSCRIBE
SUBSCRIBE

Phase 1

Drug Development
Can Merck & Co. And Novartis AG’s Surprise Heart Drug Success Translate To Blockbuster Sales?
June 29, 2017
 · 
1 min read
Drug Development
Skin Patch May Be The Future Of Flu Vaccines, Lancet Reveals
June 28, 2017
 · 
1 min read
Drug Development
Will AbbVie Outsmart Biosimilars, And Can Clovis Oncology Win The PARP Race?
June 27, 2017
 · 
1 min read
Massachusetts' Biostage Slashes 71% of Staff, Evaluating Strategic Alternatives
Drug Development
A Look at the Deaths That Plagued Juno and Kite Pharma’s CAR-T Trials
June 27, 2017
 · 
3 min read
Why This Tiny Biotech is Giving Cash to Amgen Researchers
Drug Development
Amgen Goes on the Defensive When Critics Call Its Pipeline a Dud
June 22, 2017
 · 
2 min read
BIO2017: Companies Highlight Numerous Innovations During San Diego Convention
Drug Development
BIO2017: After IPO, Full Speed Ahead for San Diego’s Tocagen
June 16, 2017
 · 
2 min read
Drug Development
While Amgen-Size Biotechs Run Into Trouble, These Are The Biotechs With The Most Promising Pipelines
June 16, 2017
 · 
1 min read
Proteostasis and Roche Diagnostics Ink Huge Space in New Boston Hub
Drug Development
New Data Reveals This New York Biotech’s Pipeline Could be a Game Changer
June 16, 2017
 · 
2 min read
Drug Development
Helsinn And MEI Pharma Announce First Patient Dosed In Phase II Dose-Optimization Study Of Pracinostat And Azacitidine In Myelodysplastic Syndrome
June 14, 2017
 · 
8 min read
3 Biotechs That Could be Taken Out This Quarter
Drug Development
Why Drug Giants Like Merck & Co. and AstraZeneca PLC Scientists are Looking in the Toilet for New Cancer Treatments
June 14, 2017
 · 
2 min read
Load More
PRESS RELEASES
Press Releases
ADARx Pharmaceuticals Presents Onvuzosiran Data Supporting Potential for Sustained Attack-Free Rates with Reduced Treatment Burden in Patients with HAE
February 27, 2026
 · 
4 min read
Press Releases
Flare Therapeutics Presents Updated FX-909 Phase 1A Data in Late-Breaking Oral Presentation at 2026 ASCO Genitourinary Cancers Symposium
February 27, 2026
 · 
6 min read
Press Releases
Neurogene Announces FDA Breakthrough Therapy Designation for NGN-401 Gene Therapy for Rett Syndrome
February 27, 2026
 · 
7 min read
Press Releases
GEMMABio Announces First Patient Dosed in CHARISMA Trial of GB221, Investigational Next‑Generation Gene Therapy for Spinal Muscular Atrophy Type 1 (SMA1)
February 26, 2026
 · 
5 min read
Press Releases
Aramis Biotechnologies announces the achievement of an important milestone with the start of a Phase 1/2 clinical trial of its vaccine in development against seasonal influenza in 728 participants
February 26, 2026
 · 
2 min read
Press Releases
New England Journal of Medicine Publishes First-in-Human Rezatapopt Data Showing Selective Reactivation of Mutant p53 in Advanced Solid Tumors
February 26, 2026
 · 
7 min read
Press Releases
SCYNEXIS Announces First Participants Dosed in a Phase 1 Single Ascending Dose and Multiple Ascending Dose Trial of Intravenous SCY-247
February 26, 2026
 · 
3 min read
Press Releases
Juvenescence successfully completes Phase 1 clinical trial of PAI-1 inhibitor and strengthens clinical development leadership
February 26, 2026
 · 
5 min read
Press Releases
TScan Therapeutics Completes Enrollment in Cohort C of Phase 1 ALLOHA™ Trial and Announces FDA Clearance of Investigational New Drug Applications for Heme Candidates TSC-102-A01 and TSC-102-A03
February 26, 2026
 · 
7 min read
Press Releases
Asahi Kasei Pharma Strengthens Preclinical Pipeline Through Exclusive Global License Agreement with Alchemedicine for Novel Lead Compounds
February 26, 2026
 · 
2 min read
Press Releases
Kivu Bioscience Presents KIVU-305 Preclinical Data at World ADC London 2026 and Advances into Phase 1 Clinical Trial
February 26, 2026
 · 
3 min read
Press Releases
Mahzi Therapeutics Announces First Patient Dosed in Phase 1/2 UNITE Study of MZ-1866 for Pitt Hopkins Syndrome
February 26, 2026
 · 
4 min read
Press Releases
Tempest Announces Interim Results from Ongoing REDEEM-1 Trial of TPST-2003, Preparing for Potential U.S. Registrational Study in 2026
February 25, 2026
 · 
11 min read
Press Releases
IDEAYA Biosciences Announces First-Patient-In for Phase 1 Trial of IDE034, a Potential First-In-Class B7H3/PTK7 Bispecific TOP1 ADC
February 25, 2026
 · 
5 min read
Press Releases
Antengene Announces Clinical Collaboration with Junshi Biosciences to Explore the Synergistic Potential of ATG-037 (Oral CD73 Inhibitor) In Combination with JS207 (PD-1/VEGF BsAb)
February 25, 2026
 · 
8 min read
Press Releases
FibroBiologics Reports Full Year 2025 Financial Results and Provides Corporate Update
February 25, 2026
 · 
7 min read
Press Releases
Serina Therapeutics Announces Dosing of First Patient in Phase 1b Registrational Trial of SER-252 for Advanced Parkinson’s Disease
February 25, 2026
 · 
6 min read
Press Releases
Vico Therapeutics Announces Patient Dosing in Twice-Annual Regimen of VO659 in Phase 1/2 Trial in Huntington’s Disease, Spinocerebellar Ataxia Type 3 and Type 1
February 24, 2026
 · 
3 min read
Press Releases
Cartography Biosciences Doses First Patient in Phase 1 Trial of CBI-1214, a Highly Specific T-Cell Engager for the Treatment of Colorectal Cancer
February 24, 2026
 · 
4 min read
Press Releases
AtomVie Global Radiopharma Supplies First Patient Dose in Radiopharm Theranostics’ Phase 1/2a Clinical Study of 177Lu-BetaBart (RV-01)
February 24, 2026
 · 
4 min read
Load More